37 studies found for:    " January 02, 2013":" February 01, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Effectiveness of an HIV-adapted IMCI Training and Supervision Programme for Community Health Workers
Conditions: Prevention of Mother-to-child Transmission of HIV;   Antenatal Health Care Utilization;   Postnatal Health Care Utilization;   Infant Feeding Practices
Intervention: Behavioral: Enhanced HIV and MCH training for CHW
22 Recruiting Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy
Condition: HIV
Intervention: Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF‐T), given via intravenous infusion.
23 Recruiting Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe
Conditions: Kaposi Sarcoma (KS);   HIV
Intervention: Other: KS structured clinical care training
24 Recruiting The Effect of Antacids and Multivitamins on Raltegravir
Condition: HIV
Interventions: Dietary Supplement: Multivitamins;   Dietary Supplement: Sodium bicarbonate;   Drug: Maalox Plus extra;   Drug: Raltegravir 400 mg
25 Recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
Conditions: Visceral Leishmaniasis;   Human African Trypanosomiasis;   Enteric Fever;   Melioidosis;   Brucellosis;   Leptospirosis;   Relapsing Fever;   Rickettsial Diseases;   HIV;   Tuberculosis;   Malaria;   Amoebic Liver Abscess
Interventions: Device: rk28 ICT;   Device: IT LEISH (rK39);   Device: Immunochromatographic HAT test;   Device: HAT Serostrip;   Device: Card Agglutination Trypanosoma Test (CATT)-10;   Device: Typhidot M;   Device: S. typhi IgM/IgG;   Device: Test-it Typhoid IgM;   Device: Test-it Leptospirosis IgM;   Device: Leptospira IgG/IgM
26 Completed Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
Conditions: HIV;   Hypercholesterolaemia
Interventions: Drug: raltegravir;   Drug: Atorvastatin
27 Recruiting Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine
Condition: HIV
Intervention: Drug: ATRIPLA
28 Recruiting A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
Condition: HIV Prevention
Intervention: Drug: emtricitabine 200mg/tenofovir 300mg
29 Recruiting FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Condition: HIV-1 Infection
Intervention: Drug: Emtricitabine/rilpivirine/tenofovir disoproxil fumarate
30 Completed Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting
Condition: HIV-1 Infection
Interventions: Drug: nevirapine;   Drug: ritonavir-boosted Lopinavir;   Drug: Tenofovir/emtricitabine;   Drug: Zidovudine/lamivudine
31 Recruiting CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM
Conditions: Patient Adherence;   HIV Seronegativity
Intervention: Device: SoC + iTab
32 Not yet recruiting Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma;   AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV-associated Hodgkin Lymphoma;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Refractory Hairy Cell Leukemia;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Stage I AIDS-related Lymphoma;   Stage II AIDS-related Lymphoma;   Stage III AIDS-related Lymphoma;   Stage IV AIDS-related Lymphoma;   T-cell Large Granular Lymphocyte Leukemia;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Drug: carmustine;   Drug: cytarabine;   Drug: melphalan;   Drug: etoposide;   Drug: O6-benzylguanine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Other: laboratory biomarker analysis
33 Recruiting HIV UPBEAT: Understanding the Pathology of Bone Disease in HIV-infected Patients.
Condition: Osteoporosis
Intervention:
34 Not yet recruiting Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes
Condition: AIDS With Tuberculosis
Intervention: Drug: Rifampicin, Isoniazid, Ethambutol, Pyrazinamide
35 Recruiting STAR - Seek, Test, and Retain. Linkages for Black HIV+, Substance-Using MSM
Conditions: Substance Abuse;   Sexual Behavior
Interventions: Behavioral: Patient Navigation (PN) Intervention;   Behavioral: Financial Incentives (FI) Intervention
36 Not yet recruiting Egrifta Replacement and Sleep Disordered Breathing
Condition: Lipodystrophy
Intervention: Drug: Tesamorelin (Egrifta)
37 Recruiting Pilot Test of a Community-based Buprenorphine Treatment Intervention
Conditions: Opioid Dependence;   Injection Drug Use
Intervention: Behavioral: Community-based buprenorphine treatment (CBBT) intervention

Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page
Indicates status has not been verified in more than two years